drugset / Trial / NCT01537354
Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a null hypothesis study. The investigators hypothesize that there will be no difference in changes in dynamic compliance when measured at 15, 30, 45 and 60 minute intervals after administration of either surfactant and there will be no differences in the number of doses needed between the two surfactants in premature infants admitted to our NICU.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-12
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “Sponsor discontinued clinical trial before enrollment of subjects.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Beractant | Other / unclassified | 100 mg/kg | Other |
| Comparator | Poractant alfa | Other / unclassified | 100 mg/kg | Other |